(MDX:TSX-V)

Why MedX?

• Commercialized a regulatory-approved highly effective skin cancer scanning telemedicine platform in 37 Countries
• Dermatologists have declared these images the “next best thing to being there” in person
• Patients can receive their  assessment and receive treatment within 72 hours after the initial screening
• Began a rollout of the DermSecure telemedicine platform, across the Netherlands in partnership with  The Netherlands Institute for Prevention and Health
  • Two skin screening clinics opened in November 2020, with more than 800 assessments on close to 500 patients completed to in 2 months using MedX's DermSecure ® platform
  • IVPG plans to expand to 41 skin assessment clinics by 2022
  • The Netherlands has a very high rate of skin cancer and our platform is receiving a strong adoption rate.  

DermSecure: A Fully Integrated Telemedicine Platform 

• Chrome browser, cloud based, secure network platform hosted by AWS
• MedX’s Patient Management System was designed by Dermatologists to capture all relevant patient information to provide a rapid  accurate assessment
• DermSecureTM makes Teledermatology accurate, efficient and integrates into current Electronic Medical Record platforms and workflow seamlessly

MedX Saves Lives While Potentially Saving Millions of Dollars In Healthcare Costs

FULL DISCLOSURE: MedX is an advertising client of AGORA Internet Relations Corp.